Singapore Is One of the Fastest Growing Bioclusters in Asia; Wave of Investments in Drug Discovery and Translationa...(ore traditional methods. Building Up ...),Health

Building Up Capabilities in Drug Discovery

Mr. Alexis Borisy, President and CEO, CombinatoRx, said: "Singapore presents strategic partnership opportunities that help to expedite our drug discovery efforts. In our drive to develop new drugs and therapies for infectious diseases, CombinatoRx has established contacts with leading research institutes and companies such as the Genome Institute of Singapore, the Singapore Immunology Network, the Singapore MIT Alliance for Research and Technology's infectious disease interdisciplinary group and the Novartis Institute for Tropical Diseases. Such partnerships are only possible in Singapore where virtually everything is located in close proximity with each other, public and private research labs, service providers and academic hospitals."

He added: "We developed our lead candidate in Infectious Disease in Singapore. The drug combination against the Hepatitis C virus is currently in the late preclinical stage and is one of the very exciting programs on deck for clinical development in Singapore."

Mr. Yeoh Keat Chuan, Executive Director, Biomedical Sciences, Singapore Economic Development Board (EDB) said: "Singapore's forward-looking environment and reliable execution allow companies to place strategic bets for the future. We have built up core capabilities in industrial, human and intellectual capital and established the Biopolis as an icon for biomedical sciences research in Asia. We are now fast building capabilities and infrastructure for translational and clinical research to facilitate drug discovery from bench to the bedside and back. In Singapore, companies can increase the value of their investments by tapping into the intensity and diversity of partnerships: with and between scientists and clinicians, regional entities, and the public and private sectors."

Forging Ahead with Translational and Clinical Research

Singapore is gaining ground in translatio
'/>"/>